ABSTRACT Background Individuals living with type 1 diabetes (T1D) are at increased risk for cardiovascular (CV) and renal complications, yet therapeutic strategies specifically targeting cardiorenal risk reduction in this population remain limited. The role of glucagon‐like peptide‐1 (GLP‐1)‐based therapies in T1D remains unclear.
Anastasios Tentolouris +5 more
wiley +1 more source
B-Type Natriuretic Peptide as a Marker of Subclinical Heart Disease in a High-Burden Emergency Department Population With Sustained Asymptomatic Hypertension. [PDF]
Souffront K +11 more
europepmc +1 more source
Structural characterization of atrial natriuretic peptide amyloid fibrils from patients with atrial fibrillation. [PDF]
Broggini L +15 more
europepmc +1 more source
The Anti-Apoptotic Effect of C-Type Natriuretic Peptide and the Regulation of NPPC in Porcine Ovarian Granulosa Cells. [PDF]
Liu X, Lu J, Zeng J, An L, Tian J, Xi G.
europepmc +1 more source
Comparative Utility of B-type Natriuretic Peptide (BNP) and N-terminal Pro-BNP (NT-proBNP) in the Management of Acute Heart Failure: A Study From a Tertiary Care Hospital in Kashmir, India. [PDF]
Ganie JA +6 more
europepmc +1 more source
The diagnostic value of N-terminal pro-B-type natriuretic peptide for low left ventricular ejection fraction by chronic kidney disease stage. [PDF]
Eren D +6 more
europepmc +1 more source
Age-adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: Diagnostic accuracy study. [PDF]
Taylor CJ +5 more
europepmc +1 more source

